1. Home
  2. DNLI vs AMR Comparison

DNLI vs AMR Comparison

Compare DNLI & AMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • AMR
  • Stock Information
  • Founded
  • DNLI 2013
  • AMR 2016
  • Country
  • DNLI United States
  • AMR United States
  • Employees
  • DNLI N/A
  • AMR 3960
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • AMR Coal Mining
  • Sector
  • DNLI Health Care
  • AMR Energy
  • Exchange
  • DNLI Nasdaq
  • AMR Nasdaq
  • Market Cap
  • DNLI 2.1B
  • AMR 2.2B
  • IPO Year
  • DNLI 2017
  • AMR N/A
  • Fundamental
  • Price
  • DNLI $14.46
  • AMR $157.21
  • Analyst Decision
  • DNLI Strong Buy
  • AMR Buy
  • Analyst Count
  • DNLI 15
  • AMR 3
  • Target Price
  • DNLI $33.85
  • AMR $160.50
  • AVG Volume (30 Days)
  • DNLI 1.7M
  • AMR 449.9K
  • Earning Date
  • DNLI 08-11-2025
  • AMR 08-08-2025
  • Dividend Yield
  • DNLI N/A
  • AMR N/A
  • EPS Growth
  • DNLI N/A
  • AMR N/A
  • EPS
  • DNLI N/A
  • AMR N/A
  • Revenue
  • DNLI N/A
  • AMR $2,371,475,000.00
  • Revenue This Year
  • DNLI N/A
  • AMR N/A
  • Revenue Next Year
  • DNLI $323.34
  • AMR $21.82
  • P/E Ratio
  • DNLI N/A
  • AMR N/A
  • Revenue Growth
  • DNLI N/A
  • AMR N/A
  • 52 Week Low
  • DNLI $10.57
  • AMR $97.41
  • 52 Week High
  • DNLI $33.33
  • AMR $255.04
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 53.04
  • AMR 71.39
  • Support Level
  • DNLI $12.92
  • AMR $113.00
  • Resistance Level
  • DNLI $15.06
  • AMR $169.27
  • Average True Range (ATR)
  • DNLI 0.78
  • AMR 6.98
  • MACD
  • DNLI 0.06
  • AMR 4.25
  • Stochastic Oscillator
  • DNLI 72.03
  • AMR 89.22

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About AMR Alpha Metallurgical Resources Inc.

Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.

Share on Social Networks: